{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:50:44Z","timestamp":1768722644692,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>With increasing interest and clinical research in male sexual disorders, it has become clear that not only psychological but also organic, neurobiological, and genetic factors may play an important role in premature ejaculation (PE).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This article provides an overview of the different treatment options both for lifelong (primary, \u201ccongenital\u201d) and acquired (secondary) PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Review of the literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Currently used treatment options for PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Treatments reviewed include psychological\/behavioral\/sexual counseling therapy, topical anesthetics, dapoxetine, and other selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and phosphodiesterase-5 (PDE-5) inhibitors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Before starting any therapy for PE, correct diagnosis has to be made considering the patient's reported intravaginal ejaculatory latency time (IELT) and the duration and type of PE. Concomitant erectile dysfunction (ED) should be either ruled out or proven by appropriate means. In uncomplicated cases of PE with stable partnerships, medical treatment represents the first-choice option with a high likelihood of success. Dapoxetine, where available, or other SSRIs provide suitable therapeutic options with a good risk\/benefit profile for patients. In complicated (\u201cdifficult-to-treat\u201d) PE patients, a combination of medication and sexual counseling should be considered the first treatment option. Combination therapies of PDE-5 inhibitors and PE-related medications should be offered to patients suffering from comorbid PE and ED, with ED treatment starting first. In those patients with severe PE\u2014IELTs of &amp;lt;30\u201360 seconds or anteportal ejaculation\u2014combination therapy of topical and oral medications can be offered and may considerably increase IELT, compared with either monotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02451.x","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T20:14:45Z","timestamp":1317672885000},"page":"335-341","source":"Crossref","is-referenced-by-count":35,"title":["An Overview of Pharmacotherapy in Premature Ejaculation"],"prefix":"10.1093","volume":"8","author":[{"given":"Hartmut","family":"Porst","sequence":"first","affiliation":[{"name":"Private Urology and Andrology Practice and Hospital , Hamburg , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"2023012308000373500_bb0010","article-title":"Human sexual inadequacy","author":"Masters","year":"1970"},{"key":"2023012308000373500_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007611-195604000-00008","article-title":"Premature ejaculation: A new approach","volume":"49","author":"Semans","year":"1956","journal-title":"South Med J"},{"key":"2023012308000373500_bb0020","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0022-5347(05)64146-8","article-title":"The neurobiological approach to premature ejaculation","volume":"168","author":"Waldinger","year":"2002","journal-title":"J Urol"},{"key":"2023012308000373500_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1743-6109.2008.01033.x","article-title":"Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation","volume":"5","author":"Janssen","year":"2009","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ijir.2008.61","article-title":"Evidence for a genetic etiology to ejaculatory dysfunction","volume":"21","author":"Jern","year":"2009","journal-title":"Int J Impot Res"},{"key":"2023012308000373500_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1743-6109.2007.00638.x","article-title":"Urologist practice patterns in the management of premature ejaculation: A nationwide survey","volume":"5","author":"Shindel","year":"2008","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/j.1743-6109.2011.02367.x","article-title":"Practical tips for sexual counseling and psychotherapy in premature ejaculation","author":"Rowland","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"2023012308000373500_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1743-6109.2011.02426.x","article-title":"What does premature ejaculation mean to the man, the woman, and the couple?","volume":"8","author":"Graziottin","year":"2011","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/00926230500442292","article-title":"Effects of a new functional-sexological treatment for premature ejaculation","volume":"32","author":"De Carufel","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"2023012308000373500_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14681990802545532","article-title":"Combination therapy for premature ejaculation: Results of a small-scale study","volume":"23","author":"Steggall","year":"2008","journal-title":"Sex Relation Ther"},{"key":"2023012308000373500_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0005-7967(86)90062-8","article-title":"Long-term outcome of sex therapy","volume":"24","author":"Hawton","year":"1986","journal-title":"Behav Res Ther"},{"key":"2023012308000373500_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF01541749","article-title":"Clinical follow-up of couples treated for sexual dysfunction","volume":"14","author":"De Amicis","year":"1985","journal-title":"Arch Sex Behav"},{"key":"2023012308000373500_bb0070","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International society for sexual medicine's guidelines for the diagnosis and treatment of premature ejaculation","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-5347(17)70462-4","article-title":"Premature ejaculation, a review of 1,130 cases","volume":"50","author":"Schapiro","year":"1943","journal-title":"J Urol"},{"key":"2023012308000373500_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","article-title":"Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation","volume":"67","author":"Atan","year":"2006","journal-title":"Urology"},{"key":"2023012308000373500_bb0085","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","article-title":"Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study","volume":"93","author":"Busato","year":"2004","journal-title":"BJU Int"},{"key":"2023012308000373500_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.ijir.3901011","article-title":"Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: A proof of concept study","volume":"15","author":"Henry","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023012308000373500_bb0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1464-410X.2006.06583.x","article-title":"Topical eutectic mixture for premature ejaculation (TEMPE): A novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation","volume":"99","author":"Dinsmore","year":"2007","journal-title":"BJU Int"},{"key":"2023012308000373500_bb0100","first-page":"37","article-title":"Emerging treatments for premature ejaculation: Focus on dapoxetine","volume":"5","author":"Hellstrom","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2023012308000373500_bb0105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1743-6109.2010.01820.x","article-title":"Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: Integrated analyses of two phase 3 dapoxetine trials","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0115","article-title":"Patient-reported outcomes and improvements in Intravaginal Ejaculatory Latency Time in dapoxetine-treated men with lifelong or acquired premature ejaculation: Phase 3 pooled analyses","author":"Porst","year":"2009","journal-title":"Poster presented at the 60th Annual Congress of the German Urological Association (DGU), 16\u201319 September 2009, Dresden, Germany"},{"key":"2023012308000373500_bb0120","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase III trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"2023012308000373500_bb0125","first-page":"33","article-title":"Abstract of the SMSNA congress, Las Vegas 2\u20135 November 2006. Evaluation of withdrawal effects with Dapoxetine in the treatment of premature ejaculation (PE)","volume":"4","author":"Levine","year":"2007","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","article-title":"Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis","volume":"16","author":"Waldinger","year":"2004","journal-title":"Int J Impot Res"},{"key":"2023012308000373500_bb0135","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1743-6109.2010.01782.x","article-title":"Disorders of orgasm and ejaculation in men","volume":"7","author":"Rowland","year":"2010","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.ju.0000132159.61156.ea","article-title":"AUA guideline on the pharmacologic management of premature ejaculation [and appendices]","volume":"172","author":"Montague","year":"2004","journal-title":"J Urol"},{"key":"2023012308000373500_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.eururo.2011.01.019","article-title":"Acupuncture vs. paroxetine for the treatment of premature ejaculation: A randomized, placebo-controlled clinical trial","volume":"59","author":"Sunay","year":"2011","journal-title":"Eur Urol"},{"key":"2023012308000373500_bb0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/0929867306666220330184544","article-title":"Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?","volume":"6","author":"Pacher","year":"1999","journal-title":"Curr Med Chem"},{"key":"2023012308000373500_bb0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"2023012308000373500_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"2023012308000373500_bb0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1464-410X.2010.09390.x","article-title":"The effects of phosphodiesterase type 5 inhibitors on penile rigidity variables during a period with no sexual stimulation: A laboratory setting double-blind study","volume":"107","author":"Gokce","year":"2010","journal-title":"BJU Int"},{"key":"2023012308000373500_bb0170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1743-6109.2008.00831.x","article-title":"Premature ejaculation: Current medical treatment and new directions (CME)","volume":"5","author":"Sadeghi-Nejad","year":"2008","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.ijir.3901420","article-title":"Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors","volume":"18","author":"Dresser","year":"2006","journal-title":"Int J Impot Res"},{"key":"2023012308000373500_bb0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1743-6109.2006.00424.x","article-title":"Tramadol HCL has promise in on-demand use to treat premature ejaculation","volume":"5","author":"Salem","year":"2008","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11255-005-3616-4","article-title":"Terazosin in the treatment of premature ejaculation: A short-term follow-up","volume":"37","author":"Basar","year":"2005","journal-title":"Int Urol Nephrol"},{"key":"2023012308000373500_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000475036","article-title":"Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy","volume":"28","author":"Cavallini","year":"1995","journal-title":"Eur Urol"},{"key":"2023012308000373500_bb0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"2023012308000373500_bb0200","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"2023012308000373500_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0090-4295(01)01151-7","article-title":"Prevalence of chronic prostatitis in men with premature ejaculation","volume":"58","author":"Screponi","year":"2001","journal-title":"Urology"},{"key":"2023012308000373500_bb0210","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1210\/jc.2005-1135","article-title":"Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients","volume":"90","author":"Carani","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2023012308000373500_bb0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1743-6109.2006.00243.x","article-title":"Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis","volume":"4","author":"El-Nashaar","year":"2007","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/009262300438760","article-title":"Ciprofloxacin as cure of premature ejaculation","volume":"26","author":"Brown","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"2023012308000373500_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1743-6109.2011.02384.x","article-title":"Pathophysiology of premature ejaculation","volume":"8","author":"Buvat","year":"2011","journal-title":"J Sex Med"},{"key":"2023012308000373500_bb0230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1743-6109.2008.01092.x","article-title":"Screening for erectile dysfunction in men with lifelong premature ejaculation\u2014Is the sexual health inventory for men (SHIM) reliable?","volume":"6","author":"McMahon","year":"2009","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515336882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515336882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/Supplement_4\/335\/48806967\/jsm_8_supplement_4_335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/Supplement_4\/335\/48806967\/jsm_8_supplement_4_335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T08:01:27Z","timestamp":1674460887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/Supplement_4\/335\/6994909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":45,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2011,10,1]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02451.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,10,1]]}}}